Yaping Hong

Yaping Hong

Auto-generated profile, based on publicly available information

Yaping Hong

Huizhou Municipal Central Hospital, Huizhou, Guangdong 516008, China

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1996 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
RBRoger P. Bakale
Roger P. Bakale
SWStephen A. Wald
Stephen A. Wald
HBHal T. Butler
Hal T. Butler
YGYun Gao
Yun Gao
YHYaping Hong
Yaping Hong
CZCharles M. Zepp
Charles M. Zepp

19 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RSRou Shi
Rou Shi
CLChunwen Lin
Chunwen Lin
YHYaping Hong
Yaping Hong
XXXiaoying Xia
Xiaoying Xia
YCYingjian Chen
Yingjian Chen
LXLiangchang Xiu
Liangchang Xiu
Objective. Free triiodothyronine (FT3) is an independent risk factor for nonalcoholic fatty liver disease (NAFLD) in patients with euthyroid. However, whether FT3 has an independent effect on NAFLD in a population of type 2 diabetes remains unknown. The purpose of this study was to identify the potential role of FT3 in NAFLD with T2DM. Design. A cross‐sectional study. Patient. A total of 859 T2DM patients who met the inclusion criteria were included. There were 506 T2DM patients without NAFLD and 353 T2DM patients with NAFLD. Methods. The independent samples t‐test or Wilcoxon rank sum test were used for continuous variables of different distribution types, while the chi‐square test was used for categorical variables. Pearson correlation analysis and linear regression were used to analyze the correlation between FT3 and clinical measurements and biochemical indicators. Multivariate logistic regression analysis was used to determine independent predictors. Results. Patients with NAFLD had higher BMI, SBP, and DBP, longer duration of T2DM, and higher islet function index, blood glucose index, liver function index, renal function index, blood lipid index, and FT3. We also found that FT3 was affected by other five indicators, including ALT, CR, GGT, TC, and LDL‐C only in the NAFLD group but not in the non‐NAFLD group. FT3 was significantly associated with NAFLD in T2DM patients, and the prevalence of NAFLD increased gradually from the lowest FT3 tertile to the highest FT3 tertile (P for trend < 0.001). Conclusion. FT3 is independently associated with NAFLD in hospitalized T2DM patients after rigorous adjustment for various metabolic parameters.